🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing market exists on messaging services, where communities with numerous of members share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in users injecting substances of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Platform Response and Material Elimination

According to TikTok, the service has removed problematic material and banned associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Trading Operations

Investigations also discovered communities with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with images of slimming results, positive reviews and detailed guides for preparing or injecting at home.

After minutes of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and promised delivery within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Inside these groups, posts show dark colored packages with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how long a injector should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram said it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to possibly significant health risks”.